Sign in
4

Changes in Ownership

Nurix Therapeutics, Inc. Filed Acc 0001549595-24-000007

Chief Legal Officer sold 1,760 shares at $7.99 ($14,063)

  • Chief Legal Officer acquired 3,924 shares (option exercise)

From the SEC's structured data for this filing

Trades in this filing

Ring Christine · Chief Legal Officer

Table I: Non-derivative

3 lines
Date Transaction Shares Price Value Owned after D/I
2024-01-30 Exercise or conversion : show line 1 in the form +1,924 17,187 D
2024-01-30 Exercise or conversion : show line 2 in the form +2,000 19,187 D
2024-01-30 Sale : show line 3 in the form −1,760 $7.99 $14,063 17,427 D
Open-market sales · 1,760 sh · avg $7.99 · $14,063

Table II: Derivative

2 lines
Date Transaction Shares Owned after D/I
2024-01-30 Exercise or conversion : show line 4 in the form Restricted Stock Units −1,924 15,393 D
2024-01-30 Exercise or conversion : show line 5 in the form Restricted Stock Units −2,000 18,000 D
Loading xslF345X05/wk-form4_1706658755.xml…